Vertex Pharmaceuticals | VRTX - 利息收入

金融业

USD 508.99

USD 27.42B

现金及等价物

USD 7.85B

USD 489.2M

USD 12.54B

USD 3.94B

USD 1.98B

USD 1.27B

USD 1.33B

6.1K

EPS每股收益

USD 4.73

股本和储备

USD 20.25B

USD 2.84B

债务利息支出

USD 3.3M

USD 120.6M

USD 106.7M

USD 131.68B

USD 1.1B

USD 2.07B

USD 1.27B

普通股股本

USD 253.3M

28.05

USD 1.39B

USD 3.33B

销售和管理费用

USD 582.2M

USD 1.77B

贸易债权人

USD 3.61B

应收帐款人

USD 2.13B

	利息收入	更改		日
AbbVie	USD 72M		13M	2026-03
Acadia Pharmaceuticals	USD 8.06M		277K	2026-03
Agios Pharmaceuticals	USD 10.8M		1.62M	2026-03
Alnylam Pharmaceuticals	USD 26.6M		32K	2026-03
Arrowhead Research	USD 16.93M		66K	2026-06
Biogen	USD 37.9M		700K	2026-03
BioMarin Pharmaceutical	USD 22.56M		3.35M	2026-03
Gilead Sciences	USD 95M		0	2026-03
Incyte	USD 38.12M		4.43M	2026-06
Insmed	USD 765K		55K	2024-09
Ionis Pharmaceuticals	USD -0.66		0.29	2024-12
J&J	USD 2.27		0.13	2026-06
Merck	USD 35M		34M	2026-03
Moderna	USD 72M		2M	2026-03
Pfizer	USD -0.04		115M	2026-06
Puma Biotechnology	USD 0.41		0.5	2024-09
Regeneron Pharmaceuticals	USD 183.3M		200K	2026-06
Sanofi	EUR 77M		17M	2026-06
Sarepta Therapeutics	USD 7M		1.74M	2026-03
Ultragenyx Pharmaceutical	USD 6M		512K	2026-03
United Therapeutics	USD 31.5M		10.3M	2026-06
Vertex Pharmaceuticals	USD 120.6M		5.8M	2026-06